Literature DB >> 15474901

Heterogeneity of schizophrenia: a study of individual neuropsychological profiles.

William S Kremen1, Larry J Seidman, Stephen V Faraone, Rosemary Toomey, Ming T Tsuang.   

Abstract

Based on a strategy developed by Seidman et al. (Seidman, L.J., Faraone, S.V., Kremen, W.S., Pepple, J.R., Lyons, M.J., Tsuang, M.T., 1993. Neuropsychological dysfunctions in the non-psychotic first-degree relatives of schizophrenic patients, Poster presented at the annual meeting of the Society for Research and Psychopathology. Chicago, IL) we examined neuropsychological heterogeneity in schizophrenia using clinical neuropsychological descriptions of individual cases as the starting point. We blindly rated neuropsychological profiles of 74 schizophrenia patients and 91 normal controls based primarily on prototypes from the clinical literature in neuropsychology. Patients were classified as having the following profile types: within normal limits (WNL) (23%, n=17), frontal/abstraction (46%, n=34), widespread/diffuse (14%, n=10), left temporal/verbal memory (8%, n=6) and other (9%, n=7). As expected based on our classification scheme, the groups had different profile shapes (group x function interactions). They were also significantly different from one another in terms of overall severity (main effects); however, severity differences were not inherent in the definition of all groups. Longer duration of illness and greater overall cognitive impairment were observed as one went from the left temporal to the frontal to the widespread groups. Longitudinal studies are needed to determine whether the different neuropsychological profiles reflect true subgroup differences or within-person change over time. Further research-probably including neuroimaging and genetic studies-will also be needed to determine the validity and the utility of this strategy for identifying neuropsychological profile types.

Entities:  

Mesh:

Year:  2004        PMID: 15474901     DOI: 10.1016/j.schres.2004.02.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  21 in total

1.  Neurocognitive and clinical dysfunction in adult Chinese, nonpsychotic relatives of patients with schizophrenia: Findings from the Changsha study and evidence for schizotaxia.

Authors:  William S Stone; Xiaolu Hsi; Liwen Tan; Shaochun Zhu; Lingjiang Li; Anthony J Giuliano; Larry J Seidman; Ming T Tsuang
Journal:  Asian J Psychiatr       Date:  2012-03

2.  Neurocognitive profile in 22q11 deletion syndrome and schizophrenia.

Authors:  Eva W C Chow; Mark Watson; Donald A Young; Anne S Bassett
Journal:  Schizophr Res       Date:  2006-06-06       Impact factor: 4.939

Review 3.  Real-world cognitive--and metacognitive--dysfunction in schizophrenia: a new approach for measuring (and remediating) more "right stuff".

Authors:  Danny Koren; Larry J Seidman; Morris Goldsmith; Phillip D Harvey
Journal:  Schizophr Bull       Date:  2006-01-05       Impact factor: 9.306

4.  Neurocognitive functioning in patients with first-episode schizophrenia : results of a prospective 5-year follow-up study.

Authors:  Margot Albus; Werner Hubmann; Fritz Mohr; Susanne Hecht; Petra Hinterberger-Weber; Nichi-Niels Seitz; Helmut Küchenhoff
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-10-09       Impact factor: 5.270

5.  Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment.

Authors:  Elsa Gilbert; Chantal Mérette; Valérie Jomphe; Claudia Emond; Nancie Rouleau; Roch-Hugo Bouchard; Marc-André Roy; Thomas Paccalet; Michel Maziade
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-31       Impact factor: 5.270

6.  Change in neuropsychological functioning over one year in youth at clinical high risk for psychosis.

Authors:  Kristen A Woodberry; William R McFarlane; Anthony J Giuliano; Mary B Verdi; William L Cook; Stephen V Faraone; Larry J Seidman
Journal:  Schizophr Res       Date:  2013-02-22       Impact factor: 4.939

7.  Grey matter and cognitive deficits in young relatives of schizophrenia patients.

Authors:  Tejas S Bhojraj; Alan N Francis; Debra M Montrose; Matcheri S Keshavan
Journal:  Neuroimage       Date:  2010-03-31       Impact factor: 6.556

8.  Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.

Authors:  Joseph L McClay; Daniel E Adkins; Karolina Aberg; Jozsef Bukszár; Amit N Khachane; Richard S E Keefe; Diana O Perkins; Joseph P McEvoy; T Scott Stroup; Robert E Vann; Patrick M Beardsley; Jeffrey A Lieberman; Patrick F Sullivan; Edwin J C G van den Oord
Journal:  Neuropsychopharmacology       Date:  2010-11-24       Impact factor: 7.853

9.  Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.

Authors:  Eva Velthorst; Eric C Meyer; Anthony J Giuliano; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Larry J Seidman
Journal:  Schizophr Res       Date:  2018-08-02       Impact factor: 4.939

10.  Heritability of neurocognitive traits in familial schizophrenia.

Authors:  Janice A Husted; Sooyeol Lim; Eva W C Chow; Celia Greenwood; Anne S Bassett
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-09-05       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.